je.st
news
SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays
2015-06-27 21:17:38| Biotech - Topix.net
SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement with the National Cancer Institute , part of the National Institutes of Health, to create reference materials and positive controls for cancer assays. The CRADA will investigate the development of methods to mix and accurately quantitate control DNA biosynthetics spiked into a genomic DNA background and cell-free circulating tumor DNA for next-generation DNA sequencing applications.
Tags: life
create
positive
sciences
Category:Biotechnology and Pharmaceuticals